Israel21c
Israel21c

since 2001

Since
  • Facebook
  • LinkedIn
  • Tiktok
  • Innovation
  • Earth
  • Life
  • Travel
  • Home
  • Innovation
  • Earth
  • Life
  • Travel
    • About
    • Team
    • Our reuse policy
    • Contact us
    • Terms and conditions
    • Privacy policy
  • Donate
  • Subscribe
  • Digital Ambassador Internship
  • CreatorClub
  • Use our content
  • Español
Keep It Magniv
Follow
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • TikTok
Subscribe to our newsletter
Get ISRAEL21c delivered straight to your inbox
Tell us which topics you like best:

hemophilia

Image by Jarun Ontakrai/Shutterstock.com
January 18 2018, 9:00 am
Possible hemophilia cure under study in Israeli hospital
PROLOR Biotech and OPKO Health researchers are working on new drug-products for hemophilia, obesity and diabetes. (Shutterstock.com)
April 25 2013, 4:13 am
OPKO Health acquires Israel’s PROLOR Biotech for $480m

You can help us tell Israel's story better!

In an era rife with political division, ISRAEL21c stands apart — we place people over politics, and introduce readers to life in Israel beyond salacious headlines. We maintain a paywall-free platform so our journalists can share the positive impact Israelis have on our world. That's because of people like you. If you believe more people should hear these stories, then please make a gift today and support our work.

Make a gift
Israel21c
Stories That Impact Our World

Read

  • Home
  • Earth
  • Innovation
  • Life
  • Travel
  • En Español

About

  • About
  • Team
  • Our Reuse Policy
  • Contact us
  • Terms & Conditions
  • Privacy Policy

Join

  • Donate
  • Subscribe
  • Syndicate our content
  • Digital Ambassador Internship
  • CreatorClub
  • Keep It Magniv

Follow

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • TikTok
  • Pinterest
Created by
Powered by Salamandra